Belinda is a research fellow with the Health System Science division and her work focuses on value based health care and evaluation of new models of care in Australia. 

She completed her PhD through the George Institute's injury division and UNSW in 2021. This research adopted a health systems approach to evaluate health care services and access for patients with chronic eye disease. Belinda has played a key role in the design, implementation and evaluation of the Western Sydney Community Eye Care (C-EYE-C) model of care as both a project manager, and through her PhD studies.

Prior to starting her PhD, Belinda has worked in a variety of research and service delivery roles with a focus on chronic and infectious, infectious disease, Aboriginal health, and primary care. Belinda has collaborated with Aboriginal Community Controlled Health Organisations (ACCHOs) to design and conduct research projects which address the local needs and priorities of the community.

Ben is a doctor from the UK and Advanced Trainee in nephrology who is completing a PhD at the George Institute. The focuses of the PhD is improving the outcomes and economics of treating chronic kidney disease with a particular interest in low-and-middle-income countries. Ben is also involved with the Affordable Dialysis Project – an initiative run by The George Institute to develop a system that can provide low cost dialysis to those who currently cannot afford it. He works as clinical advisor for this project.

Justin joined The George Institute in 2020 as Chief Financial Officer, bringing with him over 25 years of international pharmaceutical experience in both a commercial and financial capacity.  His areas of expertise span investor relations, finance, strategic planning, M&A, corporate governance and marketing. 

Prior to The George Institute, Justin was the CEO of First Pharma, a boutique privately backed pharmaceutical company.  Before this, he held several senior executive positions at AstraZeneca both in Singapore and Australia.  This included the role of Area Finance Director – Asia, Sales & Marketing Director – Australia, and Chief Financial Officer of Australia.

Justin is a member of ASCPA and holds a Commerce degree from Macquarie University.  He has also undertaken various post graduate leadership programmes at the London Business School, INSEAD and most recently MIT.

Dr Karena Conroy is an experienced health researcher and program manager/lead with a PhD in Health and a background in the social sciences. She currently leads two programs of work focussed on the development and implementation of Consumer and Community Involvement in health research, spanning The George Institute for Global Health and Sydney Local Health District. The remit of both Programs is to develop organisational strategies, structures, and processes that facilitate the systematic engagement and meaningful involvement of consumers and community members in health and medical research.

Kate is an NHS doctor in psychiatry working in Edinburgh. Her research considers women’s mental and physical health through the life course. Her current work with The George Institute is focused on the co-creation and implementation of sex and gender policies for the UK’s medical research funders. This is part of a wider initiative to recognise diversity among patients, and ensure research practices and outcomes represent everyone in our society. Kate is also a Commissioner on the BMJ Commission on the Future of the NHS.

Kate has a background in Pharmacology and a PhD in the inflammatory system. She began her employment at TGI in March 2018, mainly working within the renal and metabolic division. Kate’s clinical research operations skills developed whilst working on the REDUCCTION study where she managed sites, coordinated event adjudication processes, maintained data trackers, monitored data collection, upheld ethics and research governance approvals, submitted ethics amendments, coordinated site payments, and maintained close communication with participating study sites. Her expertise has also been lent to other studies including TRIDENT (project forecasting and coordinating outcome adjudications), TRACK (unblinded team member), RESOLVE (event verification), and ATHENA (UAT). Experience has also been obtained in start-up, site initiation, site close-out, protocol and other document development, and exposure to data linkage processes.

Kate currently manages the PERFORM-AKI, ACCESS HD, DISCOVER and REVERSE studies.

Dr Kissock is a distinguished researcher and academic specialising in nutrition, dietetics and public health. She currently holds the position of Research Fellow at The George Institute for Global Health and serves as a Conjoint Lecturer at the University of New South Wales.

Dr Kissock holds a PhD in Health Sciences from the University of Wollongong, Australia focusing on how different definitions of whole-grain foods impact health outcomes and promotional strategies. Her research in this area has been influential, with publications in leading journals.

Dr Kissock addresses critical global health issues at The George Institute, notably through her research on the development and implementation of potassium-enriched salt as a strategy to reduce cardiovascular disease risk and research on sodium reduction in China and Nigeria. Dr Kissock has presented her findings at major international conferences, and her efforts have garnered significant grants and multiple awards, reflecting her impact in the field.

Beyond her research, Dr Kissock is actively involved in academic service. She reviews for scientific journals, co-chairs the Early- and Mid-Career Researcher (EMCR) group at The George Institute, is an Early-Career Researcher committee member of the Cardiac, Vascular and Metabolic Medicine Theme at the University of New South Wales and is a member of various national and international working groups.

Dr. Kissock continues to make a significant impact on public health by enhancing the understanding and implementation of innovative dietary strategies and making substantial contributions to global health initiatives.

Kerry actively manages all peer-reviewed funding processes and procedure for TGI Australia by providing and coordinating pre-award support to all academics and researchers.

She oversees post-award management of successful research grant applications.

Kylie is Chief of Staff at The George Institute for Global Health. She has 30 years’ experience in senior government, diplomatic and consulting positions. Kylie’s areas of expertise include international business strategy and growth, partnerships and stakeholder management, and business transformation. 

Before joining The George Institute, Kylie was a Deputy Secretary in the NSW State Government, responsible for its trade and investment portfolio, including its international network of trade offices. She was a Director at global advisory firm EY, and earlier worked for the Australian Federal Government for more than 15 years in senior diplomatic roles working in India, Southeast Asia and Europe. 

Kylie holds a Bachelor of Commerce from the University of Western Sydney and has undertaken various post graduate leadership programmes, including at the Australian Graduate School of Management.

Lachlan is an intensive care specialist who works at Royal North Shore Hospital, Sydney.

Lachlan is an early career researcher and is currently enrolled in a PhD as a Scientia Scholar (UNSW) focussed on Acute Kidney Injury is Sepsis under the supervision of Prof Bala Venkatesh, Dr Naomi Hammond and Prof John Myburgh. He previously completed a Masters of Philosophy (USYD) focused on analytical bias in meta-analysis. Other research interests include Aboriginal and Torres Strait Islander outcomes in critical care, neurocritical care, burns injury and the quality of ICU survivorship for patients and their carers.

Laurent is Director of Biostatistics and Data Science at the George Institute for Global Health and Professor at the Faculty of Medicine of the University of New South Wales. He also holds an adjunct professorial appointment at the University of Bordeaux. 

His research focuses on biostatistics and their application to clinical and health services research. He is recognised internationally for his leading role in the design and analysis of large-scale trials in critical care, cardiovascular, neurological and musculoskeletal diseases.

He holds a Master of Science in Statistics and Computer Science and a Master of Research in Public Health (Biostatistics). He is an accredited statistician by the Statistical Society of Australia (AStat).

Dr. Lili Song MD PhD, is the Head of Stroke division, senior research fellow at The George Institute China, and senior lecturer at Faculty of Medicine, University of New South Wales. She has been a neurologist for 15 years and has clinical research experience for 8 years. She has worked in several GI stroke clinical trials (ENCHANTED, INTERACT, SAVE, HeadPost, TRIDENT, BEYOND 7, etc), with Professor Craig Anderson, providing academic input as well as day-to-day operational direction.

She joined The George China from 2016 and currently manages several large scale clinical trials including INTERACT3, INTERACT4, ENCHANTED2 and TRIDENT CHINA - as the main research fellow and the global project lead. She holds several small seed grants from GI and World Heart Foundation and she has successfully awarded a MRC joint funding as CIB in 2019. She is a reviewer for several high-ranking clinical journals including Stroke, Cerebrovascular Diseases and Stroke, etc. She has been selected one of 2018 Emerging Leaders by the World Heart Foundation. Now she is co-supervisor for 2 PhD students.